Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 85

1.

Hemodynamic mechanisms underlying elevated oxygen extraction fraction (OEF) in moyamoya and sickle cell anemia patients.

Watchmaker JM, Juttukonda MR, Davis LT, Scott AO, Faraco CC, Gindville MC, Jordan LC, Cogswell PM, Jefferson AL, Kirshner HS, Donahue MJ.

J Cereb Blood Flow Metab. 2016 Jan 1:271678X16682509. doi: 10.1177/0271678X16682509. [Epub ahead of print]

PMID:
28029271
2.

Insulin-like growth factor binding protein-2 interactions with Alzheimer's disease biomarkers.

Lane EM, Hohman TJ, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative..

Brain Imaging Behav. 2016 Nov 5. [Epub ahead of print]

PMID:
27817134
3.

Asymptomatic Alzheimer disease: Defining resilience.

Hohman TJ, McLaren DG, Mormino EC, Gifford KA, Libon DJ, Jefferson AL; Alzheimer's Disease Neuroimaging Initiative..

Neurology. 2016 Dec 6;87(23):2443-2450. Epub 2016 Nov 4.

PMID:
27815399
4.

Genetic resilience to amyloid related cognitive decline.

Hohman TJ, Dumitrescu L, Cox NJ, Jefferson AL; Alzheimer’s Neuroimaging Initiative..

Brain Imaging Behav. 2017 Apr;11(2):401-409. doi: 10.1007/s11682-016-9615-5.

PMID:
27743375
5.

Brain in Congenital Heart Disease Across the Lifespan: The Cumulative Burden of Injury.

Marelli A, Miller SP, Marino BS, Jefferson AL, Newburger JW.

Circulation. 2016 May 17;133(20):1951-62. doi: 10.1161/CIRCULATIONAHA.115.019881. Review.

6.

The Vanderbilt Memory & Aging Project: Study Design and Baseline Cohort Overview.

Jefferson AL, Gifford KA, Acosta LM, Bell SP, Donahue MJ, Davis LT, Gottlieb J, Gupta DK, Hohman TJ, Lane EM, Libon DJ, Mendes LA, Niswender K, Pechman KR, Rane S, Ruberg FL, Su YR, Zetterberg H, Liu D.

J Alzheimers Dis. 2016 Mar 8;52(2):539-59. doi: 10.3233/JAD-150914.

7.

Development of a subjective cognitive decline questionnaire using item response theory: a pilot study.

Gifford KA, Liu D, Romano R 3rd, Jones RN, Jefferson AL.

Alzheimers Dement (Amst). 2015 Dec 1;1(4):429-439.

8.

A Mutual Self- and Informant-Report of Cognitive Complaint Correlates with Neuropathological Outcomes in Mild Cognitive Impairment.

Gifford KA, Liu D, Hohman TJ, Xu M, Han X, Romano RR 3rd, Fritzsche LR, Abel T, Jefferson AL.

PLoS One. 2015 Nov 5;10(11):e0141831. doi: 10.1371/journal.pone.0141831. eCollection 2015.

9.

Subjective Cognitive Decline in Older Adults: An Overview of Self-Report Measures Used Across 19 International Research Studies.

Rabin LA, Smart CM, Crane PK, Amariglio RE, Berman LM, Boada M, Buckley RF, Chételat G, Dubois B, Ellis KA, Gifford KA, Jefferson AL, Jessen F, Katz MJ, Lipton RB, Luck T, Maruff P, Mielke MM, Molinuevo JL, Naeem F, Perrotin A, Petersen RC, Rami L, Reisberg B, Rentz DM, Riedel-Heller SG, Risacher SL, Rodriguez O, Sachdev PS, Saykin AJ, Slavin MJ, Snitz BE, Sperling RA, Tandetnik C, van der Flier WM, Wagner M, Wolfsgruber S, Sikkes SA.

J Alzheimers Dis. 2015 Sep 24;48 Suppl 1:S63-86. doi: 10.3233/JAD-150154.

10.

Associations between Verbal Learning Slope and Neuroimaging Markers across the Cognitive Aging Spectrum.

Gifford KA, Phillips JS, Samuels LR, Lane EM, Bell SP, Liu D, Hohman TJ, Romano RR 3rd, Fritzsche LR, Lu Z, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative..

J Int Neuropsychol Soc. 2015 Jul;21(6):455-67. doi: 10.1017/S1355617715000430.

11.

GSK3β Interactions with Amyloid Genes: An Autopsy Verification and Extension.

Hohman TJ, Chibnik L, Bush WS, Jefferson AL, De Jaeger PL, Thornton-Wells TA, Bennett DA, Schneider JA.

Neurotox Res. 2015 Oct;28(3):232-8. doi: 10.1007/s12640-015-9541-0. Epub 2015 Jul 21.

12.

Stroke risk interacts with Alzheimer's disease biomarkers on brain aging outcomes.

Hohman TJ, Samuels LR, Liu D, Gifford KA, Mukherjee S, Benson EM, Abel T, Ruberg FL, Jefferson AL; Alzheimer's Neuroimaging Initiative..

Neurobiol Aging. 2015 Sep;36(9):2501-8. doi: 10.1016/j.neurobiolaging.2015.05.021. Epub 2015 Jun 6.

13.

The role of vascular endothelial growth factor in neurodegeneration and cognitive decline: exploring interactions with biomarkers of Alzheimer disease.

Hohman TJ, Bell SP, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative..

JAMA Neurol. 2015 May;72(5):520-9. doi: 10.1001/jamaneurol.2014.4761.

14.

Low cardiac index is associated with incident dementia and Alzheimer disease: the Framingham Heart Study.

Jefferson AL, Beiser AS, Himali JJ, Seshadri S, O'Donnell CJ, Manning WJ, Wolf PA, Au R, Benjamin EJ.

Circulation. 2015 Apr 14;131(15):1333-9. doi: 10.1161/CIRCULATIONAHA.114.012438. Epub 2015 Feb 19.

15.

APOE and mild cognitive impairment: the Framingham Heart Study.

Jefferson AL, Beiser AS, Seshadri S, Wolf PA, Au R.

Age Ageing. 2015 Mar;44(2):307-11. doi: 10.1093/ageing/afu183. Epub 2014 Dec 11.

16.

Adverse vascular risk is related to cognitive decline in older adults.

Jefferson AL, Hohman TJ, Liu D, Haj-Hassan S, Gifford KA, Benson EM, Skinner JS, Lu Z, Sparling J, Sumner EC, Bell S, Ruberg FL.

J Alzheimers Dis. 2015;44(4):1361-73. doi: 10.3233/JAD-141812.

17.

Subjective memory complaint only relates to verbal episodic memory performance in mild cognitive impairment.

Gifford KA, Liu D, Damon SM, Chapman WG 4th, Romano Iii RR, Samuels LR, Lu Z, Jefferson AL; Alzheimer’s Disease Neuroimaging Initiative..

J Alzheimers Dis. 2015;44(1):309-18. doi: 10.3233/JAD-140636.

18.

Inclusion of an informant yields strong associations between cognitive complaint and longitudinal cognitive outcomes in non-demented elders.

Gifford KA, Liu D, Carmona H, Lu Z, Romano R, Tripodis Y, Martin B, Kowall N, Jefferson AL.

J Alzheimers Dis. 2015;43(1):121-32. doi: 10.3233/JAD-131925.

19.

Vascular risk factors and midlife cognition: rethinking the exposure window.

Jefferson AL.

Circulation. 2014 Apr 15;129(15):1548-50. doi: 10.1161/CIRCULATIONAHA.114.008906. Epub 2014 Mar 31. No abstract available.

20.

Gray & white matter tissue contrast differentiates Mild Cognitive Impairment converters from non-converters.

Jefferson AL, Gifford KA, Damon S, Chapman GW 4th, Liu D, Sparling J, Dobromyslin V, Salat D; Alzheimer’s Disease Neuroimaging Initiative..

Brain Imaging Behav. 2015 Jun;9(2):141-8. doi: 10.1007/s11682-014-9291-2.

Supplemental Content

Loading ...
Support Center